Denali Therapeutics (DNLI) Amortizatization of Intangibles (2017 - 2026)
Denali Therapeutics (DNLI) reported Amortizatization of Intangibles of $916000.0 for Q1 2026, up 3.27% year-over-year from $887000.0 in Q1 2025, and down 1.4% on a QoQ basis from $929000.0 in Q4 2025.
Denali Therapeutics (DNLI) has 10 years of Amortizatization of Intangibles data on file, last reported at $916000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles rose 3.27% year-over-year to $916000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (up 74.9% YoY) and the FY2025 annual result came in at $3.6 million, up 203.17% from the prior year.
- Amortizatization of Intangibles eased to $916000.0 in Q1 2026 per DNLI's latest filing, from $929000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $11.5 million in Q2 2023 and bottomed at -$1.6 million in Q1 2022.
- The 5-year median for Amortizatization of Intangibles is $900000.0 (2025), against an average of $1.9 million.
- The widest annual swing landed in 2022, when Amortizatization of Intangibles sank 40.14%; it then surged 2448.88% in 2023.
- Tracing DNLI's Amortizatization of Intangibles over 5 years: stood at $1.4 million in 2022, then jumped by 706.5% to $11.5 million in 2023, then sank by 93.09% to $797000.0 in 2024, then gained by 16.56% to $929000.0 in 2025, then declined by 1.4% to $916000.0 in 2026.
- Per Business Quant, the three latest DNLI Amortizatization of Intangibles figures stand at $916000.0 (Q1 2026), $929000.0 (Q4 2025), and $900000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Denali Therapeutics | 3.82 Bn | 3.82 Bn | - | 916,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 916,000.00 |
| Mar 31, 2026 | 916,000.00 |
| Dec 31, 2025 | 929,000.00 |
| Dec 31, 2025 | 929,000.00 |
| Sep 30, 2025 | 900,000.00 |
| Sep 30, 2025 | 900,000.00 |
| Jun 30, 2025 | 900,000.00 |
| Jun 30, 2025 | 900,000.00 |
| Mar 31, 2025 | 887,000.00 |
| Mar 31, 2025 | 887,000.00 |
| Dec 31, 2024 | 797,000.00 |
| Dec 31, 2024 | 797,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Jun 30, 2023 | 11.53 Mn |
| Jun 30, 2023 | 11.53 Mn |
| Mar 31, 2023 | 7.85 Mn |
| Mar 31, 2023 | 7.85 Mn |
| Dec 31, 2022 | 1.43 Mn |
| Dec 31, 2022 | 1.43 Mn |
| Sep 30, 2022 | 688,000.00 |
| Sep 30, 2022 | 688,000.00 |
| Jun 30, 2022 | -491,000.00 |
| Jun 30, 2022 | -491,000.00 |
| Mar 31, 2022 | -1.63 Mn |
| Mar 31, 2022 | -1.63 Mn |
| Dec 31, 2021 | -2.43 Mn |
| Dec 31, 2021 | -2.43 Mn |
| Sep 30, 2021 | -2.66 Mn |
| Sep 30, 2021 | -2.66 Mn |
| Jun 30, 2021 | -2.50 Mn |
| Jun 30, 2021 | -2.50 Mn |
| Mar 31, 2021 | -1.16 Mn |
| Mar 31, 2021 | -1.16 Mn |
| Dec 31, 2020 | -1.13 Mn |
| Dec 31, 2020 | -1.13 Mn |
| Sep 30, 2020 | 49,000.00 |
| Sep 30, 2020 | 49,000.00 |
| Jun 30, 2020 | 418,000.00 |
| Jun 30, 2020 | 418,000.00 |
| Mar 31, 2020 | 607,000.00 |
| Mar 31, 2020 | 607,000.00 |
| Sep 30, 2019 | 4.03 Mn |
| Sep 30, 2019 | 4.03 Mn |
| Jun 30, 2019 | 1.42 Mn |
| Jun 30, 2019 | 1.42 Mn |
| Mar 31, 2019 | 1.32 Mn |
| Mar 31, 2019 | 1.32 Mn |
| Dec 31, 2018 | 841,000.00 |
| Dec 31, 2018 | 841,000.00 |
| Sep 30, 2018 | 772,000.00 |
| Sep 30, 2018 | 772,000.00 |
| Jun 30, 2018 | 705,000.00 |
| Jun 30, 2018 | 705,000.00 |
| Mar 31, 2018 | 387,000.00 |
| Mar 31, 2018 | 387,000.00 |
| Dec 31, 2017 | 146,000.00 |
| Dec 31, 2017 | 146,000.00 |
| Sep 30, 2017 | -214,000.00 |
| Sep 30, 2017 | -214,000.00 |
| Jun 30, 2017 | -458,000.00 |
| Jun 30, 2017 | -458,000.00 |
| Mar 31, 2017 | -227,000.00 |
| Mar 31, 2017 | -227,000.00 |